Cannabis News

Nextleaf Solutions Ltd. (" Nextleaf Solutions ", " OILS ", or the " Company ") ( CSE: OILS ) ( OTCQB: OILFF ), Canada's most innovative cannabis extractor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (" Nextleaf Labs "), a Health Canada licensed standard processor, has entered into a Cannabis Extraction Agreement (the " Agreement ") with Natural MedCo Ltd.(" NMC "), a wholly-owned subsidiary of Eve & Co Incorporated (" E ve & Co ") ( TSX-V: EVE ) ( OTCQ B : EEVVF ). NMC is based in Strathroy, Ontario and operates over one million square feet of licensed production and distribution through provincial adult-use channels and international markets.

Cannabis Extraction Agreement

Pursuant to the Agreement, NMC will provide cannabis biomass to be processed into distilled THC and CBD oils at Nextleaf's closed-loop extraction plant in Metro Vancouver. The resulting bulk THC and CBD oils will be sold by Nextleaf Labs through its Commercial Partners Program and the wholesale market, with the net proceeds of such sales to be shared by Nextleaf Labs and NMC. The initial term of the Agreement will end on the earlier of (a) 12 months, and (b) the date upon which 5,000 kilograms of cannabis biomass has been processed, and automatically renews thereafter for successive one-year terms.

Nextleaf Solutions' investment in IP and its existing fixed asset base provides a robust platform to scale, and a clear competitive advantage to supply low-cost cannabinoid distillate produced at the Company's ultra-efficient cannabis oil refinery in British Columbia.

"We are excited for the opportunity to support the launch of Eve & Co's female-focussed cannabis 2.0 product lines in Canada," stated Nextleaf Solutions' CFO, Charles Ackerman. "Given our partner's European Union certificate of Good Manufacturing Practise Compliance, and their ability to distribute into Germany, we expect to have opportunities to supply global markets with bulk THC and CBD oils and differentiated products," continued Ackerman.

"We are excited about the opportunity to work with Nextleaf, which is such a ground-breaking company, and the opportunities our partnership will bring," said Melinda Rombouts, CEO and President of Eve & Co. "Alliance with this group adds another revenue stream, which aligns well with our 2.0 female-focussed product line and exports to the European Union."

About Nextleaf®

OILS is Canada's most innovative cannabis extractor, developing technology for extracting and distilling cannabinoids. OILS wholesales THC and CBD oils and provides extraction services through its wholly owned subsidiary Nextleaf Labs Ltd., a Health Canada licensed processor. The Company owns a portfolio of over 50 issued patents and over 50 pending patents for the extraction, purification, and delivery of cannabinoids.  The Company's proprietary closed-loop extraction plant in Metro Vancouver has a design capacity to process 600 kg per day of dried cannabis biomass into distilled oils.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow OILS across social media platforms: Twitter , LinkedIn , Facebook , and Instagram .

www.nextleafsolutions.com

For more information please contact:
Jason McBride
604-283-2301 (ext. 219)
investors@nextleafsolutions.com

On behalf of the Board of Directors of OILS,

Paul Pedersen, CEO

About Eve & Co.

Eve & Co, through its wholly-owned subsidiary NMC, holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its European Union certificate of Good Manufacturing Practice. NMC was Canada's first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario.

For further information, please contact:

Melinda Rombouts
President and Chief Executive Officer
Eve & Co Incorporated
Telephone: (855) 628-6337

Rory Taylor
Interim Chief Financial Officer
Eve & Co Incorporated
Telephone: (855) 628-6337

CAUTIONARY STATEMENT

Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company's ability to capitalize on its IP portfolio, the Company and NMC's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company and Eve & Co's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A and Eve & Co's MD&A, respectively, for the most recent fiscal period. The Company and Eve & Co's management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company and Eve & Co, as applicable. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved this press release.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

closeup of congress building on dollar bill

Cannabis Weekly Round-Up: New US Cannabis Bill Arrives, Path Forward Uncertain

A new piece of legislation geared at federal cannabis reform was introduced in the US Senate this week. However, experts aren’t confident that it will be approved by Congress.

Investors also saw a top analyst change their perspective on some cannabis companies in Canada.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

TerrAscend to Delight NJ Shoppers with an Immersive Cookies Experience

New Jersey's First-Ever Cookies Corner Opening Tomorrow at The Apothecarium Maplewood

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced with Cookies, a globally recognized cannabis and lifestyle brand, the opening of New Jersey's first-ever "Cookies Corner" at The Apothecarium location in Maplewood . Additional Cookies Corners are scheduled to launch in Lodi and Phillipsburg in the near future. All three retail spaces will offer exclusive Cookies products and accessories through an immersive, branded shopping experience.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2023 ended June 30, 2022 before financial markets open on August 5, 2022 .

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022 (CNW Group/Canopy Growth Corporation)

Following the release of its first quarter fiscal year 2023 financial results, Canopy Growth will host an audio webcast with David Klein , CEO and Judy Hong , CFO on August 5, 2022 , at 10:00 AM ET .

Management will address questions during a Q&A portion of the call related to Canopy Growth's business and financial results. Additionally, verified shareholders can submit and upvote questions in advance using a platform developed by Say Technologies. Shareholders can submit questions starting on July 29, 2022, at 10:00 am ET by visiting:

https://app.saytechnologies.com/canopy-growth-corporation-2023-q1 .

The platform will close on August 4, 2022 , at 10:00 am ET .

Webcast Information

A live audio webcast will be available at:

https://app.webinar.net/bXk1q7d6DRl

Replay Information

A replay will be accessible by webcast until 11:59 PM ET on November 5, 2022 at:

https://app.webinar.net/bXk1q7d6DRl

About Canopy Growth Corporation

Canopy Growth (TSX: WEED , NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com .

Notice Regarding Forward Looking Statements

This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward‐looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward‐looking statements and the forward‐looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2022 , filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward‐looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward‐ looking statement. Readers are cautioned not to put undue reliance on any forward‐looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-to-report-first-quarter-fiscal-2023-financial-results-on-august-5-2022-301591572.html

SOURCE Canopy Growth Corporation

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2022/22/c1953.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
cannabis plant

Canadian Producers, US States to Watch and M&A — Experts Review Cannabis in H1 2022

What do experts and executives involved in the cannabis market think of the developments seen in 2022?

At the halfway mark of the year, investments in cannabis are down, a path to federal reform in the US remains murky and the Canadian leaders of old are still bleeding cash.

Here the Investing News Network (INN) brings investors a closer look at what industry observers are thinking about the general progress for 2022 so far.

Keep reading...Show less

TERRASCEND TO HOST SECOND QUARTER 2022 EARNINGS CONFERENCE CALL

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its second quarter ended June 30, 2022 on Thursday, August 11, 2022 at 5:00 p.m. Eastern Time . The Company will report its financial results for the second quarter the same day after market close.

CONFERENCE CALL DETAILS

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend

TerrAscend is the leading North American cannabis operator with vertically integrated operations in Pennsylvania , New Jersey , Michigan and California , licensed cultivation and processing operations in Maryland and licensed production in Canada . TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com

SOURCE TerrAscend

Cision View original content: http://www.newswire.ca/en/releases/archive/July2022/21/c0218.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

American Green Launches Its Own Branded Premium Cannabis "Private Reserve" Flower in Arizona

MAC1 and Orange Apricot MAC Flower Available From ERBB

News Provided by NewMediaWire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×